Cost-effectiveness of fixed-dose combination of isosorbide dinitrate and hydralazine therapy for black patients with heart failure

被引：0
|
作者：
Tam, SW
Linde-Zwirble, WT
Worcel, M
Sabolinski, ML
Ghali, JK
Villagra, VG
Winkelmayer, WC
Angus, DC
机构：
[1] ZD Associates, Perkasie, PA USA
[2] NitroMed Inc, Lexington, MA USA
[3] Louisiana State Univ, Hlth Sci Ctr, Shreveport, LA USA
[4] Hlth & Technol Vector Inc, Farmington, CT USA
[5] Harvard Univ, Sch Med, Boston, MA USA
[6] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA
来源：
CIRCULATION | 2005年 / 112卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3031
引用
收藏
页码：U705 / U705
页数：1
相关论文
共 50 条
  • [41] Cost-effectiveness of a fixed-dose combination agent in high-risk hypertensive patients
    Faulkner, MA
    Hilleman, DE
    Reyes, AP
    AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (05) : 105A - 105A
  • [42] Isosorbide Dinitrate and Hydralazine as Therapy for African Americans with Heart Failure; a Failed Paradigm?
    Yancy, Clyde W.
    Feldman, Arthur
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2009, 2 (04): : 309 - 311
  • [43] Fixed-dose isosorbide dinitrate-hydralazine: Race-based cardiovascular medicine benefit or mirage?
    Ferdinand, Keith C.
    JOURNAL OF LAW MEDICINE & ETHICS, 2008, 36 (03): : 458 - 463
  • [44] Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine - Consistency across subgroups in the African-American Heart Failure Trial
    Taylor, Anne L.
    Ziesche, Susan
    Yancy, Clyde W.
    Carson, Peter
    Ferdinand, Keith
    Taylor, Malcolm
    Adams, Kirkwood
    Olukotun, Adeoye Y.
    Ofili, Elizabeth
    Tam, S. William
    Sabolinski, Michael L.
    Worcel, Manuel
    Cohn, Jay N.
    CIRCULATION, 2007, 115 (13) : 1747 - 1753
  • [45] Beta 1 adrenergic receptor Gly389Arg polymorphism and the impact of fixed-dose combination of isosorbide dinitrate/hydralazine in heart failure: Results from the A-HeFT trial
    McNamara, DM
    Tam, SW
    Sabolinski, ML
    Tobelman, P
    Palmer, A
    Janosko, K
    Feldman, AM
    Worcel, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 67A - 67A
  • [46] COST-EFFECTIVENESS ANALYSIS OF FIXED-DOSE TRIPLE COMBINATION THERAPY (LINAGLIPTIN/METFORMIN/EMPAGLIFOZIN) VS. ITS FIXED-DOSE DOUBLE COMBINATION AND INDIVIDUAL COMPONENTS
    Winberg, D.
    Shi, L.
    VALUE IN HEALTH, 2023, 26 (06) : S100 - S100
  • [47] Early, sustained event-free survival from fixed-dose isosorbide dinitrate/hydralazine: Increased survival is consistent across subgroups in advanced heart failure
    Taylor, AL
    Ziesche, S
    Yancy, CW
    Carson, P
    Ferdinand, K
    Taylor, M
    Adams, K
    Olukotun, A
    Ofili, E
    Sabolinski, M
    Worcel, M
    Cohn, JN
    JOURNAL OF CARDIAC FAILURE, 2005, 11 (06) : S149 - S149
  • [48] LOW USAGE OF HYDRALAZINE AND ISOSORBIDE DINITRATE THERAPY IN ELIGIBLE HEART FAILURE PATIENTS DURING HOSPITALIZATION OR AT DISCHARGE
    Opoku-Asare, Isaac
    Kassim, Thaslim A.
    Napan, Sirikan
    Singh, Steve
    JOURNAL OF INVESTIGATIVE MEDICINE, 2011, 59 (03) : 629 - 629
  • [49] FEWER DEATHS OR HOSPITALIZATIONS FOR HEART FAILURE USING HYDRALAZINE-ISOSORBIDE MONONITRATE COMPARED TO HYDRALAZINE-ISOSORBIDE DINITRATE IN PATIENTS WITH SYSTOLIC HEART FAILURE
    Peltzer, Bradley
    Nag, Tonusri
    Kim, Yekaterina
    Weiss, Allen
    Kumar, Salil
    Shulman, Eric
    Shin, J. Julia
    Patel, Snehal
    Saeed, Omar
    Jorde, Ulrich
    Sims, Daniel
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 867 - 867
  • [50] Usefulness of Isosorbide Dinitrate and Hydralazine as Add-on Therapy in Patients Discharged for Advanced Decompensated Heart Failure
    Mullens, Wilfried
    Abrahams, Zuheir
    Starling, Randall C.
    Young, James B.
    Taylor, David O.
    Tang, W. H. Wilson
    Francis, Gary S.
    Sokos, George
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 103 (08): : 1113 - 1119
12345